Colocalization of different types of amyloid in the walls of cerebral blood vessels of patients suffering from cerebral amyloid angiopathy and spontaneous intracranial hemorrhage: a report of 5 cases.
Four cases of spontaneous intracranial hemorrhage (ICH) are described in which the diagnosis of a cerebral amyloid angiopathy (CAA) was made in the biopsy specimens. In one further case CAA was detected on autopsy after intracranial hemorrhage (ICH). Amyloidotic degeneration of the vessel walls appeared to be the most likely reason for the ICH which in these cases especially involved superficial neocortical regions. In all cases, co-deposition of A4beta-amyloid and ALlambda-amyloid was found in diseased leptomeningeal and cortical vessels. Besides CAA, all 5 patients suffered from other diseases which had affected the blood vessel walls such as atherosclerosis, diabetes mellitus or arterial hypertension. However, no signs of systemic amyloidosis could be detected in these cases. It is suggested that the observed co-deposition of 2 amyloid subtypes is based on the combination of 2 different diseases, one of which results in a local production of A4beta-amyloid in the tunica media of cerebral blood vessels and another one, e.g. arterial hypertension, which impairs the permeability of the blood vessels by affection of the tunica intima allowing for the pathological penetration of circulating immunoglobulin lambda-light chains into the vessel wall. Subsequently, the preexisting A4beta-amyloid might have induced the polymerization of the lambda-light chains to ALlambda-amyloid in the media of the vessels and could have aggravated the amyloidotic degeneration of the vessel walls.
Galuske
R A W
RA
Institute of Neurology of the University (Edinger Institute), Johann Wolfgang Goethe University, Frankfurt/Main, Germany.
Drach
L M
LM
Nichtweiss
M
M
Marquardt
G
G
Franz
K
K
Bohl
J
J
Schlote
W
W
D000328:Adult; D000368:Aged; D016229:Amyloid beta-Peptides / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology*; D001921:Brain / Q000098:blood supply* / Q000000981:diagnostic imaging / Q000473:pathology; D002463:Cell Membrane Permeability / Q000502:physiology; D016657:Cerebral Amyloid Angiopathy / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D002540:Cerebral Cortex / Q000098:blood supply / Q000000981:diagnostic imaging / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D007146:Immunoglobulin lambda-Chains / Q000378:metabolism; D020300:Intracranial Hemorrhages / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D058225:Plaque, Amyloid / Q000378:metabolism / Q000473:pathology*; D000685:Serum Amyloid A Protein / Q000378:metabolism; D014057:Tomography, X-Ray Computed
D016229:Amyloid beta-Peptides; D007146:Immunoglobulin lambda-Chains; D000685:Serum Amyloid A Protein